Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Office Actions › Biomagnetic Solutions LLC › 16320531
Last updated: May 29, 2026
Application No. 16/320,531

SIMULTANEOUS SEPARATION AND ACTIVATION OF T CELLS FROM BLOOD PRODUCTS WITH SUBSEQUENT STIMULATION TO EXPAND T CELLS

Non-Final OA
Filed
Jan 25, 2019
Priority
Jul 26, 2016 — provisional 62/366,696 +1 more
Examiner
MIANO, JOSEPH PAUL
Art Unit
1631
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Biomagnetic Solutions LLC
OA Round
6 (Non-Final)
38%
Grant Probability
At Risk
6-7
OA Rounds
0m
Est. Remaining
99%
With Interview

Interview Optional

— +63.3% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 38% grant rate with +63.3% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.
Based on 103 resolved cases, 2023–2026

Examiner Intelligence

MIANO, JOSEPH PAUL View full profile →
Grants only 38% of cases
38%
Career Allowance Rate
39 granted / 103 resolved
-22.1% vs TC avg
Strong +63% interview lift
Without
With
+63.3%
Interview Lift
resolved cases with interview
Typical timeline
4y 2m
Avg Prosecution
31 currently pending
Career history
159
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
67.3%
+27.3% vs TC avg
§102
4.4%
-35.6% vs TC avg
§112
6.4%
-33.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 103 resolved cases

Prosecution Timeline

Show 17 earlier events
Sep 06, 2024
Response after Non-Final Action
Feb 10, 2025
Non-Final Rejection mailed
Jun 04, 2025
Examiner Interview Summary
Jun 04, 2025
Applicant Interview (Telephonic)
Jun 10, 2025
Response Filed
Jun 10, 2025
Response after Non-Final Action
Sep 11, 2025
Final Rejection mailed
Mar 11, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

18/333,705
Patent 12558381
DEVELOPMENT OF AMNION-LIKE TISSUE FROM HUMAN PLURIPOTENT STEM CELLS
2y 5m to grant Granted Feb 24, 2026
16/301,374
Patent 12551507
FAT AND MEDICAL USES THEREOF
7y 3m to grant Granted Feb 17, 2026
17/212,296
Patent 12550885
RED BLOOD CELL STORAGE SOLUTIONS, SOLUTION ADDITIVES, AND METHODS FOR IMPROVING THE STORAGE OF RED BLOOD CELLS
4y 11m to grant Granted Feb 17, 2026
16/632,362
Patent 12534706
METHOD FOR MATURATION OF RETINAL TISSUE CONTAINING CONTINUOUS EPITHELIUM
6y 0m to grant Granted Jan 27, 2026
16/764,692
Patent 12480091
STREAMLINED METHODS FOR MAKING LIQUID MEDIA
5y 6m to grant Granted Nov 25, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

6-7
Expected OA Rounds
38%
Grant Probability
99%
With Interview (+63.3%)
4y 2m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 103 resolved cases by this examiner. Grant probability derived from career allowance rate.

Ready to respond to this office action?

IP Author drafts your complete OA response — amendments, arguments, and claim strategy — in minutes, not days.

Start Drafting Your Response →

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month